Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRIVE-C: Integrated HCV Care Model for PWID in Vietnam
NCT03537196Phase 4Completed
- Sponsor
- ANRS
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir, daclatasvir in hepatitis C (HCV), sponsored by ANRS. Started Nov 2018; status: completed.
02
Drugs
sofosbuvirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03537196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537196.